Summary
In a significant market movement during August 2021, SolasCure was the subject of a vc funding. The transaction achieved a gross valuation of £15,000,000. Leading the round was RAIN Biotech AG, EVA Pharma, Seneca Partners, Dr Jonathan Milner, Development Bank of Wales, Bionova Capital, François Fournier.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
RAIN Biotech AG
Lead Investor / Acquirer
EVA Pharma
Lead Investor / Acquirer
Seneca Partners
Lead Investor / Acquirer
Dr Jonathan Milner
Lead Investor / Acquirer
Development Bank of Wales
Lead Investor / Acquirer
Bionova Capital
Lead Investor / Acquirer
François Fournier
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in